2021年2月21日星期日

DeepFck!n Value BursaBets Here in KLSE - BIMB-WA

 

Author:    |    Publish date: 


DeepFck!n Value BursaBets Here in KLSE : BIMB-WA

 

Most people have the “grass is greener on the otherside” mindset. However, without looking any further, we have our Own DeepFck!nValue counter in Malaysia too- BIMB-wa.


Introduction for BIMB and BIMB-wa


News Analysis:

On 11 December 2019, announcement made by BIMB to undertake restructuring exercise to unlock value, transfer listing to Bank Islam. One of the condition caught our attention.
Other aspects of the restructuring include a Scheme of Arrangement (SOA) by BIMB to settle its outstanding warrants, whereby BIMB warrant holders would be paid a cash consideration for the cancellation of exercise rights in respect of the warrants.”

https://www.theedgemarkets.com/article/bimb-undertake-restructuring-exercise-unlock-value-transfer-listing-status-bank-islam


BIMB-wa was issued to the renounceable rights of 426,715,958 shares of RM1 each in BIMB Holding Berhad.  Now, We dont have to look at the Exercise price for all these warrants, because at the end of the day, BIMB will settle all the warrants with cash. 


And recently 29/1/2021, BIMB announced a new condition;

(ii) the Warrants Consideration, which was originally proposed to be RM0.26 per Warrant via the First Announcement, has been revised such that the Warrants Consideration shall now be determined based on the five (5)-day VWAP of the Warrants immediately preceding the price-fixing date for the Warrants Consideration but shall in no event be lower than RM0.26 per Warrant.” https://malaysiastock.biz/Company-Announcement.aspx?id=1291884

Meaning to say that, regardless of what the price of warrants are, BIMB will buy back from market, using its 5 days VWAP before the price fixing date, and it will not be lower than RM0.26.
Well, isnt this a JACKPOT ? As you can see that your downside is already fixed, RM0.26,  while the upside (depending on the price fixing date) will be unlimited ?

Technical analysis:

As you can see after the announcement made by BIMB on 29 Jan 2021, many smart investors rushed in to buy BIMB-WA. Any price below RM0.26 is a sure win. Price of RM0.26 is sure wont lose. However anything above, you already can see your downside is RM0.26, but, the upside is unlimited until they decided on the price fixing date.

Also, lets compare other company warrants;

As seen above, BIMB-WA is comparable to those fundamentally strong stocks such as SCIENTX-wc and KPOWER-wa which warrants are at least RM0.85 and RM0.895. 

Conclusion:

We believe in risk management when it comes to trading. When we know what is our definite downside, we already know the risk we are taking when taking a trade. The Reward to Risk ratio for BIMB-WA is 5.1 if the price goes to RM0.40 and sustain.

Previously, BIMB buy back the BIMB-WA for a maximum of RM0.260, however with this recent announcement, the buy back of the BIMB-WA is for MINIMUM of RM0.260. This tells us that BIMB are willing to pay to buy back the BIMB-WA for their restructuring plan to take place. 

 

What will you do ?

DISCLAIMER: This post serves as an educational analysis and is never meant to be a buy/sell call or recomendation. Investors must always do their own due deligence before making any investment decisions. The author of this post is not liable in any way for any decisions made by any individual.

NOTION VTEC BERHAD (0083)

 


Last PriceChangeVolume
KLSE Market Watch  
Open: Day Range: Prev Close: 


OTHERS Notion VTec Berhad ("NVB" or "the Company") - New Business Activities in the Healthcare Industry

NOTION VTEC BERHAD

TypeAnnouncement
SubjectOTHERS
Description
Notion VTec Berhad ("NVB" or "the Company") - New Business Activities in the Healthcare Industry

We refer to the Company's announcement dated 30 October 2020 in relation to New Business Activities in the Healthcare Industry.

 

The Board of Directors (“Board”) wishes to announce that Notion Venture Sdn Bhd ("NVSB"), a wholly owned subsidiary of the Company, has obtained a Certificate of Registration from Registrar Corp certified that NVSB is registered with the U.S. Food and Drug Administration (“FDA”) for Financial Year 2021 for the Polymer Patient Examination Glove. Please note that the Company needs a 510(k), a premarket submission to FDA demonstrates that the device to be marketed is safe and effective and the submission is currently underway.

 

Also, the Company has submitted the necessary documents to apply for the European Conformity (CE) marking certification for the nitrile gloves from the European Union and the approval is expected to be obtained soon.

 

Both certifications are necessary for marketing the nitrile gloves in the USA and Europe, in which the Company’s nitrile gloves is currently supplied by Original Equipment Manufacturers, and brand building of the “Novid” brand will be taking place before the Company’s gloves production starts in middle of 2021.

 

Furthermore, the Company is also engaging with potential glove buyers on Manufacturing Lease Agreement on some gloves lines to be set up. NVB will dedicate all the output of the lines to glove buyers on a Cost Plus basis with an upfront leasing charge over a period of 24 months. By doing so, it is able to mitigate risks of NVB.

 

The Company will make further announcements whenever there is any material development on the above business activities.

 

This announcement is dated 2 November 2020.



Last PriceChangeVolume
KLSE Market Watch  
Open: Day Range: Prev Close: 



Changes in Director's Interest (Section 219 of CA 2016)

NOTION VTEC BERHAD

Information Compiled By KLSE

Particulars of Director

NameMR CHOO WING HONG
Descriptions(Class)Ordinary Shares

Details of changes

No
Date of change
No of securities
Type of transaction
Nature of Interest
1
23/10/2020
1,000,000
Acquired
Direct Interest
Name of registered holderChoo Wing Hong
Description of "Others" Type of Transaction
Consideration (if any)1.1775

Circumstances by reason of which change has occurred
Purchase of Ordinary Shares via open market
Nature of interest
Direct Interest

Total no of securities after change

Direct (units)52,582,939
Direct (%)10.216
Indirect/deemed interest (units)0
Indirect/deemed interest (%)0.000
Date of notice27/10/2020
Date notice received by Listed Issuer27/10/2020


Remarks :
After change, the direct interest are as follows:- (i) Choo Wing Hong - 31,582,939 Ordinary Shares (ii) RHB Capital Nominees (Tempatan) Sdn Bhd - Pledged Securities Account for Choo Wing Hong - 21,000,000 Ordinary Shares The percentage of holding is based on the issued share capital of 514,711,156 Ordinary Shares. This announcement is also made to comply with Paragraph 14.09 of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad.


Announcement Info

Company NameNOTION VTEC BERHAD
Stock NameNOTION
Date Announced27 Oct 2020
CategoryChanges in Director's Interest Pursuant to Section 219 of CA 2016
Reference NumberCS4-24102020-00006

VTEC Turbo Engine Starting Soon - NOTION VTEC (0083)


Author:    |    Publish date: 


VTEC Turbo Engine Starting Soon - NOTION VTEC (0083)

For the Past 2 weeks in the global market, especially in USA, we saw that anything Elon Musk (Tesla Ceo) tweeted essentially would move the market, ie: GameStop (GME) and Bitcoin. Well if only Elon Musk would tweet about our KLSE stocks, then things would definitely be interesting!
 

Nevertheless, lets get back to our VTEC Turbo Engine Starting Soon - NOTION VTEC (0083)


 

Company Analysis:

NOTION (0083) is involved in:

1. Digital Storage- making of HDD which is growing with the usage of shingled magnetic recording (SMR) and helium drive which enhances GB storage. 

 

2. Health Care products- NOVID masks and Nitrile gloves. Notion(0083) is dynamically adaptable and is quick to act to venture in to the “hot-covid themed business”. On 2 Nov 2020, they already acquired the FDA for nitrile gloves https://malaysiastock.biz/Company-Announcement.aspx?id=1271161 . Notion(0083) also secured a RM337mil contract to supply nitrile gloves. https://www.thestar.com.my/business/business-news/2020/09/22/notion-vtec-secures-rm337mil-nitrile-glove-supply-contract 

 

As for Face Masks they also received FDA already. Website is as follows; https://www.novid.my/ 

 

3. EMS accessories segment where the main focus is to fabricate, laser cut, robotic laser welding, surface finishing, and many other services to suit clients needs. 

 

4. Automotive segment . 

 

Share buyback Analysis:

Recently Mr Choo Wing Hong(managing director & executive director) acquired 1,000,000 units of Notion (0083) at RM1.1775, a 34.5% premium compared to RM0.875 (closing on 29/1/2021).

https://malaysiastock.biz/Company-Announcement.aspx?id=1269559  

 

Technical Analysis:

 

 

NOTION (0083) is changing from down trend to Up-trend by forming Higher Lows as seen in the chart. Immediate resistance is at RM0.885 should this resistance be broken the next resistance is RM0.985. 

With support of RM0.840, the Reward to Risk ratio is 3.30.

 

Conclusion:

We strongly believe that NOTION(0083) is a guided by management who is quick to act to position themselves in the current themed business. As for the future where electrical cars, Artificial Intelligent , 5G and Technology dominates, will the management of Notion(0083) once again react fast enough to penetrate such market ?

 

What will you do ?

DISCLAIMER: This post serves as an educational analysis and is never meant to be a buy/sell call or recomendation. Investors must always do their own due deligence before making any investment decisions. The author of this post is not liable in any way for any decisions made by any individual.

 

Potentially Super Growth in 2021

 


Author:    |    Publish date: 


Potentially Super Growth in 2021

 

Welcome back to “The Huat Project”. Today we would like to emphasize on a stock which Potentially Super Growth in 2021 - SCOMNET (0001).

 

While many have already lose steam the COVID-19 Theme, or the Healthcare Sector, We would like to present SCOMNET(0001), as they are ready to experience exponential growth in 2021 despite being “related” to the Healthcare sector. 

 

From our understanding, SCOMNET(0001) is actually a TECHNOLOGY company, who manufactures high-end tech for medical industry, “An Industry-Leading Automated Medical Manufacturer”.

 

Analyst Opinion:

RAKUTEN analyst Vincent says its a “buy” with target price of RM2.68

 

 


UOB Kay Hian analyst says its a “buy” with target price of RM2.40



SCOMNET(0001) is also the top stock pick for 2021 as per The Star reported. 

https://www.thestar.com.my/business/business-news/2021/01/02/stock-picks-for-2021 

 

Fundamental Analysis

 

SCOMNET(0001) main customers are USA based Edward Lifescience, Denmark based Ambu & Mermaid Medical which are well known medical leaders in the industry.

 

SCOMNET(0001) is a net cash company with 56mil in their balance sheet, and ZERO borrowings.


Analysts estimate an averagely of RM30mil for FY20, and the quarter results should be released before end of February. If previous 3 quarter hey did about RM16mil, what will happen to stock price if a sudden surge of profit to RM14mil for the forth quarter ? again this is based on the analyst estimate of RM30mil for FY20. For FY21, Rakuten Analyst estimates profit of RM50.5mil, well isnt that almost double of FY20?

 

Will stock price double as well? We do not know but we know that SCOMNET (0001) is well positioned for a exponential growth in 2021

 

Technical Analysis:

SCOMNET(0001) will most likely break out from the interim resistance for RM2.16 to retest its previous high of RM2.38. With RM2.00 as support, the Reward to Risk Ratio is about 4 times.

 

Conclusion:

 

We strongly believe that SCOMNET(0001) is ready to experience a SUPER GROWTH in 2021. With the FY20 earning estimates of RM30mil, and previous 3 quarters done about total of RM16mil, will the coming 4th quarter results be RM14mil? If RM14mil we believe the stock price will sky rocket to new high uncharted areas.

 

The forth quarterly financial results should be released before end of February.


What will you do ? 

 

DISCLAIMER: This post serves as an educational analysis and is never meant to be a buy/sell call or recommendation. Investors must always do their own due diligence before making any investment decisions. The author of this post is not liable in any way for any decisions made by any individual.

接种疫苗推高需求 全球缺124亿只手套


Nanyang Tue, Feb 16, 2021 07:20pm - 4 days ago



(吉隆坡16日讯)冠病疫苗接种进展愈发乐观,分析员相信从中期来看,各国接种疫苗期间将推高橡胶手套需求,并预计今年全球手套供应短缺将达到124亿只,进而扶持平均售价。

丰隆投行研究分析员指出,在可预见的未来内,疫苗的推出和冠病检测频率升高,有助于提振手套需求及平均售价。

分析员同时表示,在今年的剩余时间里,接种疫苗带动的手套需求量增幅,将抵消冠病检测频率下滑造成的需求萎缩。

“由于全球疫苗推广才刚刚成形,我们预计手套平均售价暂时会保持在较高水平,即每1000只115至140美元。”

分析员也认为,最早也得在今年末季,才会看见手套平均售价下滑。

随着现有手套商积极提高产能,及有新业者进军分一杯羹,今年手套供应量预计扩大20%。

但分析员估计,今年内手套供应短缺仍会达到124亿只。

另一方面,分析员也举出两大理由,力证手套需求不会在短期内陷入萎缩。

第1个理由,是各国疫苗运输系统仍存在各种问题,分析员指出,这源于部分国家医疗资源捉襟见肘,及疫苗储藏方式众说纷纭。

“尽管美国已分发6000万剂疫苗,但截至今年2月8日,只有4240万剂被接种。”

“另外,虽然美国计划在首季让全民接种疫苗,但物流问题会拖累整个过程。”

此外,分析员也引用美国知名公共卫生专家福奇的说法指,需有70%至85%人接种疫苗,才能达到群体免疫效果。

“假设没有重大物流问题,美国预计在今年末季,才能达到群体免疫,明年首季则实现全民接种。”

牛转新机 | 电讯牛股不容忽视

 


Author:    |    Publish date: 


政府在2021年优先推行国家数码基建计划(JENDELA),预料将为特定电讯股注入很强的牛气,造就牛年的电讯业牛股,特别是马电讯(TM,4863,主板电讯媒体组)及时光网(TIMECOM,5031,主板电讯媒体组)崛起为首选,值得关注它们将溢出的财富。

分析员指出,政府致力在全国改善及加强数码联系及宽频的基建设施,马电讯及时光网将是最大赢家,它们将通过在国内固定宽频市场的渗透率,进一步提高国内市场占有率。

分析员指出,国内移动电讯将升级至4G,并关闭3G以及拓宽4G网络到97%的人口覆盖率,现有2G/3G站点将升级,预料新的4G站点将在2021-2022年建成。

这些新的4G站点将位于偏远和农村地区,并将由USP基金全额资助。现有4G站点的回传将升级到光纤(或至少一级跳到使用微波传输光纤),以增加平均值速度,从25Mbps提升至35Mbps。

3G网络将在2021年杪关闭,营运商可以重新部署4G的2100MHz频谱,从而推动更快速度,更大的网络容量,更有效地利用频谱。

手套股仍然获得强劲需求推动,预计销量将受需求驱动,使手套公司的盈利赚幅保持稳定,因为它们偏高的工厂利用率将有助转化为规模经济优势。

这使安联星展研究依然看好顶级手套(TOPGLOV,7113,主板医疗保健组)、贺特佳(HARTA,5168,主板医疗保健组)及高产柅品(KOSSAN,7153,主板医疗保健组)为牛年首要时势牛股。给它们的12个月合理目标价,分别为10令吉40仙、20令吉80仙及11令吉20仙,这使它们尚具吸引力,因比市价拥有相当高的潜在溢价。

谈到手套股的业务前景,安联星展研究指出,全球手套市场需求是由销量增长所推动。

预计冠病疫情和产能扩张将继续支持及应付市场对手套的需求。

分析员预计手套业2019-2021年的3年复合年增长率高达24%。一些国家和地区已经开始接种冠病疫苗,效果拭目以待。从疫苗的制造、分销和管理来看,要达到整体免疫所需剂量尚需花费一段时日。

美国的疫苗制造药剂公司──辉瑞公司及其德国合作伙伴BioNTech生产的疫苗,需要摄氏零下70度的存储温度,这可能会给后勤物流带来挑战。

因此,该行认为2021牛年的手套需求仍强劲。最重要的是,疫苗的推出还将支持手套需求,因为疫苗管理也需要使用手套。

手套原料的供应日益紧张,可能会限制丁腈手套的新入行的产能。手套业的主要业者顶级手套、贺特佳及高产柅品应该能够确保原料足够,特别是考虑到他们的规模,以及供应商与他们的长期良好关系,使它们拥有足够的原料供应。

预计手套原料价格将走高,主要是供应趋紧,直到2021年底的需求将持续增长,惟产品平均售价有增无减也带来盈利赚幅,足以抵销原料涨价。

该行认为,劳力短缺和更严格的劳动要求,也将增加新业者的挑战。预测大马手套生产商的手套销量,将在2021-2022财政年分别增加24%及8%。这使财测还有进一步上升空间,特别是持续出现需求与供应不平衡。

总结

预料马股有望在2021金牛年上演疫后回弹戏码,各行业将如“八仙过海”各显神通,若选股得当,将在这个牛年捉住牛角向上冲,赚得盘满钵满笑呵呵。!(下篇)

Fret not for Malaysia’s GLOVEs ‘still has legs to run’

 

HighlightsJoin the community of active traders. Membership is FREE. Already a member? Sign in.

gloveharicut

Author: gloveharicut    |   Latest post: Sun, 21 Feb 2021, 8:46 AM

  


Author:    |    Publish date: 


{{{PM me to join GLOVE Private Discussion Room}}}

I invite you to read my blog and make a smart GLOVE decision.

https://klse.i3investor.com/blogs/gloveharicut/blidx.jsp

 

I am reproducing the Focus Malaysia Article to my blog.

This post don't have any value added content.

Compile here for my own record.

Please skip if you don't like it.

 

https://focusmalaysia.my/markets/fret-not-for-malaysias-rubber-glove-sector-still-has-legs-to-run/

Fret not for Malaysia’s rubber glove sector ‘still has legs to run’

 
 
 

SENTIMENT towards the glove sector has doubtlessly changed – as evident on the stock price regression of the Big Four glove counters – given the rapid development on the COVID-19 vaccine scene.

Some investors have increasingly shifted their focus to recovery beneficiaries which has led share price correction of glove stocks across the board on Bursa Malaysia.

On the other hand, most glove companies expect 2021 to be a stronger year for them due to higher volume as a result of their production expansion coupled with higher average selling prices (ASPs) compared to 2020.

Some players expect sequential quarter ASP growth to continue into 3Q CY2020. While this is possible, MIDF Research opined that the rise will be at a smaller quantum due to the high-base effect.

“ASPs have more than doubled in 2020 compared to 2019,” the research house pointed out in a thematic report that focuses on the glove sector.

“We do not discount the possibility of softening blended ASPs in the second half when urgent sales start to soften.”

This is more likely to impact the spot price segment which is usually quoted at a higher selling price compared with contract orders. That said, the research house does not expect ASPs to decline sharply because demand may continue to exceed supply.

“With industry players projecting shortage in nitrile gloves that could possibly last until 2023 due to the shortage in raw material supply, ASPs for rubber gloves are expected to remain robust in the next 18 to 24 months,” projected MIDF Research.

“We view that high raw material prices will lend support to ASP of nitrile gloves.”

While industry players are expanding at a faster pace to keep up with demand, the research house reckoned that this is not done without challenges.

Other than the shortage in nitrile rubber, the industry is also facing labour shortage due to the closure of international borders.

The established glove players expect to further automate their processes in order to reduce number of workers per million pieces.

“The four companies under our coverage expanded by an estimated 21% in CY2020 compared to the preceding year when demand growth was estimated at 25%,” observed MIDF Research.

“Production challenges are among the main reasons why industry players foresee that demand will exceed supply in the near future.”

Going forward, the research house acknowledged that companies under its coverage are looking to further improve their products and manufacturing processes through research & development (R&D) as well as sharpening their business strategies.

All-in-all, MIDF Research maintained its positive view on the sector as it believes that demand growth will continue after the COVID-19 pandemic.

“Malaysia supplies about 65% of the world’s total rubber gloves which means collectively, Malaysian glove companies have market leader advantages,” justified the research house.

“The mature ecosystem in the country which has been built over a period of more than three decades, is expected to allow the established players to continue to remain efficient and competitive in the long term.”

On this note, MIDF Research maintained its “buy” recommendations on all the Big Four glove makers – Hartalega Holdings Bhd (target price: RM18.25), Top Glove Corp Bhd (TP: RM8.29), Kossan Rubber Industries Bhd (TP: RM7.33) and Supermax Corp Bhd (TP: RM13.83). – Feb 19, 2021